Market Closed -
Other stock markets
|
Pre-market 13:48:00 | |||
3.15 USD | +3.28% |
|
5.585 | +77.30% |
02:39pm | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Amid Uncertainty Ahead of Key Inflation Data | MT |
01:54pm | Top Premarket Gainers | MT |
Chart calendar Alimera Sciences, Inc.
Upcoming events on Alimera Sciences, Inc.
Past events on Alimera Sciences, Inc.
14/05/2024 14:00 | Q1 2024 Earnings Call |
14/05/2024 12:30 | Q1 2024 Earnings Release |
09/05/2024 22:30 | Association for Research in Vision and Ophthalmology Conference - Abstract Number: 6454 |
08/05/2024 | Retina World Congress |
07/05/2024 16:30 | Association for Research in Vision and Ophthalmology Conference - Poster Number: A0170 |
07/03/2024 14:00 | Q4 2023 Earnings Call |
07/03/2024 12:30 | Q4 2023 Earnings Release |
06/11/2023 00:45 | American Academy Of Ophthalmology Meeting |
02/11/2023 | American Academy Of Ophthalmology Meeting - David Chin-Yee |
02/11/2023 | American Academy Of Ophthalmology Meeting - Mathew MacCumber |
02/11/2023 | American Academy Of Ophthalmology Meeting - Daniel Kiernan |
26/10/2023 14:00 | Q3 2023 Earnings Call |
26/10/2023 12:00 | Q3 2023 Earnings Release |
13/10/2023 19:43 | The Retina Society Scientific Meeting |
13/10/2023 19:40 | The Retina Society Scientific Meeting |
13/10/2023 19:34 | The Retina Society Scientific Meeting |
13/10/2023 19:30 | The Retina Society Scientific Meeting |
11/10/2023 21:17 | The Retina Society Scientific Meeting |
11/09/2023 16:30 | H.C. Wainwright Global Investment Conference |
10/08/2023 14:00 | Q2 2023 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 53,9 51,6 4.56% | 50,8 50,0 1.55% | 59,0 54,8 7.71% | 54,1 54,7 -1.01% | 80,8 78,8 2.45% | 106 |
EBITDA Million USD | Released Forecast Spread | 0,02 -1,27 101.66% | 3,49 3,81 -8.27% | 0,00 0,00 - | 0,00 0,00 - | 8,71 9,20 -5.32% | 21,1 |
EBIT Million USD | Released Forecast Spread | -5,27 -7,22 26.9% | -0,50 -0,11 -339.47% | -0,20 0,89 -122.71% | -11,6 -10,6 -10% | -1,93 -0,61 -219.34% | 4,96 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,2 -12,9 20.47% | -5,41 -4,41 -22.62% | -3,93 -2,71 -45.01% | -18,1 -16,6 -8.62% | -20,0 -13,4 -49.1% | -8,05 |
Net income Million USD | Released Forecast Spread | -10,4 -13,0 19.89% | -5,34 -4,78 -11.64% | -4,37 -3,20 -36.69% | -18,1 -16,7 -8.69% | -21,4 -13,1 -63.37% | -3,44 |
EPS USD | Released Forecast Spread | -2,19 -2,74 19.96% | -1,04 -0,91 -13.87% | -0,66 -0,47 -40.43% | -2,59 -2,39 -8.6% | -0,79 -0,56 -40.24% | -0,07 |
Announcement Date | 26/02/20 | 24/02/21 | 24/02/22 | 31/03/23 | 07/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 11,9 12,9 -7.77% | 14,6 13,1 11.17% | 13,6 15,0 -9.63% | 14,0 14,6 -4.02% | 13,5 12,3 10.13% | 17,5 20,5 -14.24% | 23,4 22,7 2.85% | 26,3 24,3 8.06% | 23,0 22,3 3.42% | 25,8 | 27,3 | 29,9 | 25,9 | 29,6 |
EBITDA Million USD | Released Forecast Spread | -2,40 -3,20 25.16% | 0,87 1,20 -27.17% | 5,42 2,20 146.27% | 5,03 4,90 2.65% | 1,80 2,01 -10.07% | 4,49 | 5,99 | 8,80 | 3,20 | 6,60 | ||||
EBIT Million USD | Released Forecast Spread | -4,15 -3,51 -18.15% | -1,97 -3,35 40.99% | -3,41 -1,46 -134.27% | -2,11 -1,07 -97.84% | -3,30 -3,42 3.38% | -1,21 1,93 -162.75% | 1,85 0,91 104.75% | 0,72 2,06 -64.77% | -2,30 -0,97 -137.73% | 0,69 | 1,94 | 4,66 | 0,00 | 3,40 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,96 -4,79 -24.32% | -3,10 -4,68 33.73% | -5,25 -2,79 -88.26% | -3,78 -2,35 -61.2% | -4,97 -4,80 -3.58% | -10,0 -0,06 -17000.85% | -1,30 -0,78 -67.22% | -3,77 -0,90 -319.33% | -6,28 -3,11 -101.74% | -2,38 | -1,16 | 1,78 | ||
Net income Million USD | Released Forecast Spread | -5,96 -4,79 -24.32% | -3,12 -4,68 33.37% | -5,26 -2,79 -88.69% | -3,78 -2,35 -61.16% | -4,98 -4,80 -3.87% | -10,7 -0,06 -18187.18% | -1,93 -0,78 -148.07% | -3,78 -0,90 -320.11% | -6,25 -3,11 -100.72% | -1,92 | -0,67 | 2,05 | -2,30 | 1,10 |
EPS USD | Released Forecast Spread | -0,85 -0,69 -23.19% | -0,45 -0,67 32.84% | -0,75 -0,40 -87.5% | -0,54 -0,34 -61.19% | -0,71 -0,52 -37.86% | -1,32 0,01 -26500% | -0,06 0,12 -150% | -0,07 0,00 - | -0,12 -0,06 -111.75% | -0,04 | -0,01 | 0,04 | -0,03 | 0,03 |
Announcement Date | 09/05/22 | 27/07/22 | 14/11/22 | 31/03/23 | 15/05/23 | 10/08/23 | 26/10/23 | 07/03/24 | 14/05/24 | - | - | - | - | - |
11/07/2024 07:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
15/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
22/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 07:00 | BIOGAIA AB: Q2 2024 Earnings Release |
23/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 06:00 | UCB: Q2 2024 Earnings Release |
25/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
29/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Alimera Sciences, Inc.
23/05/2024 10:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
14/05/2024 16:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
13/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
09/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
09/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
09/05/2024 21:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
09/05/2024 21:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
09/05/2024 07:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
08/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
08/05/2024 21:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALIM Stock
- Calendar Alimera Sciences, Inc.